Medication info
Cansata Plus Tablet (Candesartan Cilexetil, Hydrochlorothiazide)

Cansata Plus Tablet (Candesartan Cilexetil, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Light orange oblong tablets with a score line on one side
Packaging
30 tablets/bottle, 100 tablets (10 tablets/PTP x 10) (for export)
Approval status
Active

MFDS item code 201007708 · Notified 2010.12.24 · Insurance code 648102980

Summary

Main use
Treatment of essential hypertension not controlled with individual component therapy
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medicine, the dose of candesartan cilexetil should first be adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is achieved in most patients within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: In patients at risk of hypotension, such as those who may have volume depletion, adjustment of the candesartan cilexetil dose is recommended (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with individual component therapy

  • Essential hypertension
View approved original text

This medicine is used for patients with essential hypertension who do not achieve sufficient control with individual component therapy. Essential hypertension is a condition where blood pressure is persistently high, placing burden on the cardiovascular system, and this medication helps in situations where combination therapy is necessary. It effectively controls blood pressure and helps in preventing complications, thus playing an important role in the management of hypertension and aiding in the improvement of the patient's condition.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with or without food. 1) Adults: Before switching to this medicine, the dose of candesartan cilexetil should first be adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may be considered. The antihypertensive effect is achieved in most patients within 4 weeks of starting treatment. 2) Elderly patients: No dose adjustment of this medicine is necessary in elderly patients. 3) Patients with intravascular volume depletion: In patients at risk of hypotension, such as those who may have volume depletion, adjustment of the candesartan cilexetil dose is recommended (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and a creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance less than 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to the ingredients in this medication or those with specific kidney or liver disorders, angioedema, gout, electrolyte imbalances, etc., should not take this drug. Patients with reduced blood volume or liver disease and those with specific heart conditions should use this medication with special caution. The hydrochlorothiazide component can affect the body's electrolyte balance, so blood levels of potassium, sodium, and others should be regularly monitored. While taking this medication, mild side effects such as headache, dizziness, fatigue, and nausea may occur, and rarely serious allergic reactions or renal function impairment may manifest. Interactions may occur when taken with other antihypertensive medications, diuretics, certain antibiotics, analgesics, etc., so it is essential to consult with healthcare professionals. Pregnant or nursing women should not take this medication, and especially upon confirmation of pregnancy, they should stop taking it immediately and seek alternative treatment options. Safety and efficacy have not been adequately established in children and adolescents under 18 years of age. Elderly patients should be closely managed as there is a risk of excessive blood pressure reduction when taking this medication. In case of overdose, symptoms such as hypotension, dizziness, and electrolyte imbalances may occur, requiring immediate medical attention at a healthcare facility. This medication should be stored out of reach of children and kept in its original container to prevent quality degradation and misuse. Caution is advised when driving or operating machinery, as dizziness or fatigue may occur.

Side effects

  • Headache
  • back pain
  • dizziness
  • respiratory tract infection
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infection
  • nausea
  • contusion
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • atrioventricular block
  • vomiting
  • dyslipidemia
  • nasopharyngitis
  • cough
  • elevated blood glucose
  • increased serum uric acid
  • elevated ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • elevated urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • vertigo
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • elevated liver enzyme levels
  • abnormal liver function
  • hepatitis
  • deep vein thrombosis
  • sensory abnormalities
  • transient blurred vision
  • choroidal exudate
  • acute myopia
  • acute angle-closure glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • loss of appetite
  • appetite loss
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus erythematosus-like reaction
  • activation of lupus erythematosus
  • muscle cramps
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylaxis
  • jaundice
  • sleep disturbances
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • ear pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to keep it in a cool place below 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Light orange oblong tablets with a score line on one side

Package unit

30 tablets/bottle, 100 tablets (10 tablets/PTP x 10) (for export)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.